Torrent Pharmaceuticals Limited (TORNTPHARM) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

Total Cash From Operating Activities Chart for Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited (TORNTPHARM) operating cash flow for FY2026 was INR 26.3B, a 1.8% change from FY2025. Torrent Pharmaceuticals Limited's operating cash flow grew from INR 252.0M in 2005 to INR 26.3B in 2026 (10345.9% over 21 years). Operating cash flow compound annual growth rate: 5-year CAGR of 5.5%, 10-year CAGR of -0.3%, 20-year CAGR of 24.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.